#cardiology--Biome Analytics, the leading cardiovascular performance management company, announced today that Brian Maher, MPH, has been appointed as the new Vice President of Business Development. Br...
SAN FRANCISCO: #cardiology--Biome Analytics, the leading cardiovascular performance management company, announced today that Brian Maher, MPH, has been appointed as the new Vice President of Business Development.
Brian brings a wealth of experience to Biome Analytics with 20 years of consultative support to hundreds of health care systems and industry partners. He joins Biome after nearly a decade with Abbott, where he assisted in the commercialization of Abbott’s Digital Health Solutions division and products associated with EMR integration and optimization. Previously, he served as the program director for The Advisory Board Company’s Cardiovascular Roundtable, which produced strategic guidance and disseminated best practices to over 1,200 heart and vascular programs.
“Brian Maher’s appointment is a significant step forward in our mission to revolutionize cardiovascular care. His strategic acumen, knowledge of the market, and ability to help solve complex problems will help fuel our growth ambitions,” said Stuart Jacobson, Biome’s Chief Executive Officer.
Stephen Hiscott, Chief Growth Officer, commented, “We are delighted to welcome Brian to the Biome team. His deep understanding of the healthcare landscape and thought leadership will undoubtedly propel Biome to new heights, enabling us to better serve our partners and ultimately improve patient outcomes.”
“Today’s cardiovascular program leaders face a challenging dilemma – how to achieve profitable growth while delivering superior clinical outcomes at the lowest expense possible. I’m thrilled to join Biome, as it is abundantly clear that Biome has both the technology, services, and vision drive targeted, transformative change for as many health care systems as possible,” said Brian Maher, MPH, Vice President of Business Development.
About Biome Analytics
Biome (www.biome.io) is the leading cardiovascular performance company dedicated to helping physicians and health systems deliver the best care to the most patients at the lowest cost. We partner with ambitious enterprise heart centers and cardiovascular teams looking to achieve superior clinical and financial performance. Clients rely on our proprietary machine learning, human-enabled technology, and our community-driven knowledge network to activate their data assets, engage physicians, and accelerate performance improvement. Within days of onboarding, clients gain actionable insights with minimal impact on IT resources.
Fonte: Business Wire
Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE
The Italian IoT company is in the US for the second phase of CALL4INNOVIT
The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming
Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…
The "New Zealand Buy Now Pay Later Business and Investment Opportunities Databook - Q2 2024 Update" report has been added to ResearchAndMarkets.com's…
The "Kenya Buy Now Pay Later Business and Investment Opportunities Databook - 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis,…
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.…
RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces that Mark Lawyer has joined…